Translate
About
Ketamineone Capital Limited (PINK:KONEF) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 16 2023
Wellbeing Provides Bi-Weekly Default Status Report
Feb 15 2023
Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
Feb 14 2023
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
Jan 18 2023
Wellbeing Digital Announces Change of Auditor
Dec 22 2022
Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
Financials
Revenue
$6.44 M
Market Cap
$1.3 K
EPS
-0.04